findmyKOL
Clinical trialNCT04627428RecruitingPhase 1/PHASE2Interventional

Safety and Tolerability of RPE Stem Cell-derived RPE(RPESC-RPE) Transplantation in Patients With Dry Age-related Macular Degeneration (AMD)

SponsorLuxa Biotechnology, LLCEnrollment18Dry Age-related Macular Degeneration
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • David S Liao, MD, PhD

    Retina-Vitreous Associates Medical Group

    Principal Investigator
  • Rajesh C Rao, M.D.

    University of Michigan Kellogg Eye Center

    Principal Investigator
  • Theodore Leng, MD, FACS

    Spencer Center for Vision Research at Stanford University

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Retina Vitreous Associates Medical Group

    Beverly Hills, California, United States

    Recruiting
  • Spencer Center for Vision Research

    Palo Alto, California, United States

    Recruiting
  • University of Michigan Kellogg Eye Center

    Ann Arbor, Michigan, United States

    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
5 Apr 2022
Primary completion
1 Dec 2026
Completion
1 Dec 2026
Last update posted
15 Oct 2025
Registered enrollment
18
Registry id
NCT04627428

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.